Growth in cell ther­a­py clin­i­cal pro­grams means Charles Riv­er boosts of­fer­ings in Mem­phis

While Charles Riv­er Lab­o­ra­to­ries has had its at­ten­tion on the UK and Ire­land over the past year, the com­pa­ny is look­ing to make its next ex­pan­sion in­to the Bluff City of Mem­phis, TN.

Ac­cord­ing to the out­sourc­ing com­pa­ny, it is plan­ning to boost its cell ther­a­py man­u­fac­tur­ing ca­pa­bil­i­ties at the Mem­phis site, adding nine pro­cess­ing suites and bring­ing the to­tal num­ber of suites to 23. The ex­pan­sion plans to add the man­u­fac­ture of both clin­i­cal and com­mer­cial au­tol­o­gous and al­lo­gene­ic cell and gene-mod­i­fied cell ther­a­py prod­ucts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER